Breaking News Instant updates and real-time market news.

WFM

Bought by AMZN

$27.96

-0.07 (-0.25%)

, KR

Kroger

$29.15

0.305 (1.06%)

11:51
10/06/16
10/06
11:51
10/06/16
11:51

Whole Foods says does not comment on takeover speculation, Bloomberg reports

A Whole Foods spokesperson told Bloomberg that the company's policy is not to comment on takeover speculation. The comment was issued after market participants attributed today's strength in Whole Foods shares to unconfirmed speculation Kroger (KR) may make a bid for the company. The Fly, in fulfilling its mission of explaining stock movement, often comes across the many unconfirmed rumors being passed through trading desks and social media platforms. On the occasion that rumors or speculation appear on The Fly's news feed, it should be viewed not as giving credence to the conjecture, rather as simply highlighting its impact on the stock prices of the companies involved. Near midday, shares of Whole Foods are up $1.30, or 3.7%, to $28.99.

WFM

Bought by AMZN

$27.96

-0.07 (-0.25%)

KR

Kroger

$29.15

0.305 (1.06%)

WFM Bought by AMZN
$27.96

-0.07 (-0.25%)

07/26/16
GSCO
07/26/16
DOWNGRADE
GSCO
Sell
Whole Foods downgraded to Sell from Neutral at Goldman
Goldman analyst Stephen Tanal assumed coverage Whole Foods with Sell rating from a Neutral rating with a $31 price target. Tanal said Whole Foods is losing share in its core natural and organic business to a variety of competitors that have raised the bar and driven a consistent deceleration in Whole Foods' same-store-sales and its first negative comps in Q4 2016 since 2009.
07/26/16
07/26/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) and Time Warner (TWX) downgraded to Market Perform from Outperform at FBR Capital with analyst Barton Crocket saying Disney's stock "will struggle to deliver much upside" from current levels. The analyst lowered his price target for the shares to $108 from $111. The analyst downgraded Time Warner citing valuation. 2. Chipotle (CMG) downgraded to Sell from Hold at Stifel with analyst Paul Westra citing the firm's belief that the U.S. economy will probably enter a recession within nine months. 3. Whole Foods (WFM) downgraded to Sell from Neutral at Goldman with analyst Stephen Tanal saying Whole Foods is losing share in its core natural and organic business to a variety of competitors that have raised the bar and driven a consistent deceleration in Whole Foods' same-store-sales and its first negative comps in the fourth quarter of 2016 since 2009. 4. BJ's Restaurants (BJRI) downgraded to Sell from Buy at Stifel with analyst Paul Westra citing the firm's belief that the U.S. economy will probably enter a recession within nine months. 5. Yahoo (YHOO) downgraded to Equal Weight from Overweight at Morgan Stanley with analysts led by Brian Nowak saying shares going forward will solely be viewed as a trading vehicle for its 15% Alibaba (BABA) stake with the investment thesis related to shares closing the estimated 39% liquidity discount to fair market value. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/16
FBCO
08/04/16
NO CHANGE
Target $40
FBCO
Outperform
Whole Foods added to US Focus List at Credit Suisse
09/23/16
LEHM
09/23/16
INITIATION
Target $30
LEHM
Equal Weight
Whole Foods initiated with an Equal Weight at Barclays
Barclays analyst Karen Short started Whole Foods Market with an Equal Weight rating and $30 price target.
KR Kroger
$29.15

0.305 (1.06%)

08/24/16
OPCO
08/24/16
NO CHANGE
Target $40
OPCO
Outperform
Kroger should be bought on any weakness, says Oppenheimer
Oppenheimer analyst Rupesh Parikh believes Kroger's underlying cash generation remains "very strong," which suggests that its shares could be approaching a near-term bottom, and recommends buying the stock of any weakness. Nonetheless, the analyst acknowledges that the top line likely remains "very challenging," and expects another comp shortfall amid a difficult deflationary and an increasingly promotional environment. Parikh reiterates an Outperform rating and $40 price target on the shares.
08/29/16
SBSH
08/29/16
NO CHANGE
Target $43
SBSH
Buy
Kroger Q2 sales could miss expectations, says Citi
Citi analyst Alvin Concepcion believes Kroger is likely to meet Q2 earnings expectations but that its sales could fall short of estimates. Kroger is likely to post Q2 ID ex-fuel sales of 1.6%, below the consensus of 2.5%, due to worsening deflation, Concepcion tells investors in a pre-earnings research note. Volume was healthy, but likely not enough to offset the deflationary pressure, the analyst argues. The Q2 earnings release could drive further share weakness, which would present a buying opportunity, Concepcion writes. He lowered his price target for Kroger shares to $43 from $44 and keeps a Buy rating on the name.
09/12/16
WELS
09/12/16
NO CHANGE
WELS
Kroger long-term risk/reward positive, says Wells Fargo
Wells Fargo says that Kroger's revised EPS guidance should ease investors' concerns and limit the decline of the stock. Wells trimmed its valuation range on the stock to $37-$38 from $40-$41 based on the company's comp deceleration and its belief that Kroger may have difficulty generating EBIT growth in 2017. Nonetheless, the firm thinks that the stock's current valuation makes its long-term risk/reward ratio positive. It keeps an Outperform rating on the shares.
09/23/16
LEHM
09/23/16
INITIATION
Target $33
LEHM
Equal Weight
Kroger initiated with an Equal Weight at Barclays
Barclays analyst Karen Short started Kroger with an Equal Weight rating and $33 price target.

TODAY'S FREE FLY STORIES

LNG

Cheniere Energy

$44.12

0.64 (1.47%)

07:09
09/26/17
09/26
07:09
09/26/17
07:09
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHK

Chesapeake

$4.37

0.15 (3.55%)

07:09
09/26/17
09/26
07:09
09/26/17
07:09
Hot Stocks
Chesapeake sees Q3 production 542,000 boe per day »

Chesapeake Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

KTOS

Kratos Defense

$12.72

-0.28 (-2.15%)

07:08
09/26/17
09/26
07:08
09/26/17
07:08
Hot Stocks
Kratos Defense receives $9.7M in contract awards »

Kratos Defense announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVGN

Evogene

$4.54

0.23 (5.34%)

07:08
09/26/17
09/26
07:08
09/26/17
07:08
Hot Stocks
Evogene reports 'positive' results in 2nd year field trials in banana »

Evogene announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
Axovant Phase 3 Alzheimer's study misses co-primary endpoints »

Axovant Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AST

Asterias

$3.25

0.05 (1.56%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
Asterias receives regulatory clearance to start AST-VAC2 clinical trial »

Asterias Biotherapeutics,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MDXG

MiMedx

$12.35

-0.28 (-2.22%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
MiMedx announces confidential lawsuit settlement with terminated employee »

MiMedx Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 13

    Nov

  • 14

    Nov

DRI

Darden

$83.14

0.26 (0.31%)

07:06
09/26/17
09/26
07:06
09/26/17
07:06
Hot Stocks
Darden reports Q1 Olive Garden same-restaurant sales up 1.9% »

Reports Q1 same…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AGN

Allergan

$211.61

6.96 (3.40%)

07:05
09/26/17
09/26
07:05
09/26/17
07:05
Recommendations
Allergan analyst commentary  »

Allergan weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZRE

Azure Power

$16.18

0.18 (1.13%)

07:05
09/26/17
09/26
07:05
09/26/17
07:05
Hot Stocks
Azure Power awarded 260 MW solar project in Gujarat »

Azure Power announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEES

H&E Equipment

$26.97

-0.2 (-0.74%)

07:04
09/26/17
09/26
07:04
09/26/17
07:04
Initiation
H&E Equipment initiated  »

H&E Equipment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$0.94

0.093 (10.98%)

07:04
09/26/17
09/26
07:04
09/26/17
07:04
Hot Stocks
Northern Oil and Gas announces settlement with former CEO »

Northern Oil and Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$83.14

0.26 (0.31%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Breaking Hot Stocks news story on Darden »

Darden reports Q1 Olive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BTX

BioTime

$2.72

-0.08 (-2.86%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
BioTime announces 'positive' secondary, long-term data from Renevia trial »

BioTime announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MBRX

Moleculin Biotech

$2.41

-0.07 (-2.82%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Moleculin Biotech announces FDA approval of Annamycin IND »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNCA

Genocea

$5.33

0.04 (0.76%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Downgrade
Genocea rating change  »

Genocea downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Darden reports Q1 blended same-restaurant sales from legacy brands up 1.7% »

Q1 same-restaurant sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Axovant Sciences »

Axovant announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$83.14

0.26 (0.31%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Earnings
Darden backs FY18 adjusted cont ops EPS view $4.38-$4.50, consensus $4.47 »

The company reaffirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:01
09/26/17
09/26
07:01
09/26/17
07:01
Hot Stocks
Akebia saya Phase 2 vadadustat study confirmed findings from previous studies »

Akebia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

07:00
09/26/17
09/26
07:00
09/26/17
07:00
General news
FX Update: The dollar has been in rally mode »

FX Update: The dollar has…

DIS

Disney

$99.57

0.97 (0.98%)

06:59
09/26/17
09/26
06:59
09/26/17
06:59
Periodicals
Disney streams theme-park events in new prototype stores, Bloomberg says »

Walt Disney is opening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

SPX

S&P 500

06:59
09/26/17
09/26
06:59
09/26/17
06:59
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.